NAII Reports Q2 2025 Results: Revenue Stable, Net Loss Persists

TL;DR

NAII Q2 2025: Revenue flat, still losing money. $6.2M rev, $3.3M loss.

AI Summary

Natural Alternatives International Inc. reported its Q2 2025 results for the period ending December 31, 2024. The company's revenue for the six months ended December 31, 2024, was $6,198,778, with a net loss of $3,280,721. This compares to revenue of $6,200,185 and a net loss of $3,282,128 for the same period in the prior year.

Why It Matters

This filing provides insight into the financial performance of Natural Alternatives International Inc. for the second quarter of fiscal year 2025, impacting investor understanding of the company's profitability and operational trends.

Risk Assessment

Risk Level: medium — The company continues to report net losses, indicating potential financial instability or challenges in achieving profitability.

Key Numbers

• $6.2M — Revenue (6 months ended 12/31/2024) (Slightly down from the prior year's comparable period.)
• $3.3M — Net Loss (6 months ended 12/31/2024) (Consistent with the prior year's net loss.)

Key Players & Entities

• Natural Alternatives International Inc. (company) — Filer
• 2024-12-31 (date) — Period End Date
• $6,198,778 (dollar_amount) — Revenue for six months ended 12/31/2024
• $3,280,721 (dollar_amount) — Net loss for six months ended 12/31/2024
• $6,200,185 (dollar_amount) — Revenue for six months ended 12/31/2023
• $3,282,128 (dollar_amount) — Net loss for six months ended 12/31/2023

FAQ

Key Financial Figures

• $0.01 — ange on Which Registered Common Stock, $0.01 par value per share NAII Nasdaq Sto

Filing Documents

• naii20241231_10q.htm (10-Q) — 1247KB
• ex_750664.htm (EX-31.1) — 8KB
• ex_750665.htm (EX-31.2) — 9KB
• ex_750666.htm (EX-32) — 5KB
• 0001437749-25-004002.txt ( ) — 6400KB
• naii-20241231.xsd (EX-101.SCH) — 52KB
• naii-20241231_cal.xml (EX-101.CAL) — 42KB
• naii-20241231_def.xml (EX-101.DEF) — 365KB
• naii-20241231_lab.xml (EX-101.LAB) — 297KB
• naii-20241231_pre.xml (EX-101.PRE) — 395KB
• naii20241231_10q_htm.xml (XML) — 1182KB

Financial Statements

Financial Statements 2 Condensed Consolidated Balance Sheets 2 Condensed Consolidated Statements of Operations and Comprehensive Loss 3 Condensed Consolidated Statements of Stockholders' Equity 4 Condensed Consolidated Statements of Cash Flows 6 Notes to Condensed Consolidated Financial Statements 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 4.

Controls and Procedures

Controls and Procedures 19 PART II OTHER INFORMATION 20 Item 1.

Legal Proceedings

Legal Proceedings 20 Item 1A.

Risk Factors

Risk Factors 20 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20 Item 3. Defaults Upon Senior Securities 20 Item 5. Other Information 20 Item 6. Exhibits 21

SIGNATURES

SIGNATURES 22 Table of Contents SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS Certain statements in this report, including information incorporated by reference, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect current views about future events and financial performance based on certain assumptions. They include opinions, forecasts, intentions, plans, goals, projections, guidance, expectations, beliefs, or other statements that are not statements of historical fact. Words such as "may," "will," "should," "could," "would," "expect," "plan," "believe," "anticipate," "intend," "estimate," "approximate," "predict," "forecast," "project," "future," or "likely," or the negative or other variation of such words, and similar expressions may identify a statement as a forward-looking statement. Any statements that refer to projections of our future financial performance, our anticipated growth and trends in our business, our goals, strategies, focus and plans, and other characterizations of future events or circumstances, including statements expressing general optimism or pessimism about future operating results, are forward-looking statements. Forward-looking statements in this report may include statements about: our ability to develop market acceptance for and increase sales of new products, develop relationships with new customers and maintain or improve existing customer relationships; future financial and operating results, including projections of net sales, revenue, income or loss, net income or loss per share, profit margins, expenditures, liquidity, and other financial items; the sufficiency of our available cash and cash equivalents, including continued access to borrowings under our credit facilities, and potential cash flows from our operations to fund our work

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS Natural Alternatives International, Inc. Condensed Consolidated Balance Sheets (In thousands, except share and per share data) (Unaudited) December 31, 2024 June 30, 2024 Assets Current assets: Cash and cash equivalents $ 8,663 $ 11,981 Accounts receivable – less allowance for credit losses of $ 129 at December 31, 2024 and $ 0 at June 30, 2024 16,898 16,891 Inventories, net 23,036 24,249 Income tax receivable 921 — Forward contracts 1,043 492 Prepaids and other current assets 7,986 7,997 Total current assets 58,547 61,610 Property and equipment, net 50,939 52,211 Operating lease right-of-use assets 42,303 43,537 Deferred tax asset – noncurrent 3,125 3,170 Other noncurrent assets, net 1,214 1,814 Total assets $ 156,128 $ 162,342 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 8,597 $ 12,740 Accrued liabilities 2,250 2,847 Accrued compensation and employee benefits 2,128 2,090 Customer deposits 1,165 302 Short-term liability – operating leases 1,932 1,194 Forward contracts 275 91 Income taxes payable — 505 Mortgage note payable, current portion 301 296 Line of credit – current 5,000 3,400 Total current liabilities 21,648 23,465 Long-term liability – operating leases 45,659 46,468 Long-term pension liability 159 141 Mortgage note payable, net of current portion 8,781 8,933 Income taxes payable, noncurrent 740 740 Total liabilities 76,987 79,747 Commitments and contingencies (Notes E, F, and L) Stockholders' equity: Preferred stock; $ .01 par value; 500,000 shares authorized; none issued or outstanding — — Common stock; $ .01 par value; 20,000,000 shares authorized at December 31, 2024 and June 30, 2024, issued and outstanding (net of treasury shares) 6,198,778 at December 31, 2024 and 6,200,185 at June 30, 2024 93 93 Additional paid-in capital 33,187 32,634 Retained earnings 68,793 72,966 Treasury st

View Full Filing

View this 10-Q filing on SEC EDGAR